	Des Atouts		Date
Celltrion	KRW 21.08T	530.63B	2025-09
Cspc Pharmaceutical	CNY 46B	1.61B	2025-06
Deva Holding AS	TRY 12.93B	1.83B	2023-09
Dianthus Therapeutics	USD 577.44M	251.37M	2025-09
Divis Laboratories Ltd	INR 181.51B	12.19B	2025-09
Eli Lilly	USD 112.48B	2.46B	2025-12
Kangmei Pharma	CNY 13.68B	38.19M	2025-09
Knight Therapeutics	CAD 962.29M	16.93M	2024-09
Laboratorios Farma	EUR 799.88M	99.95M	2023-12
Malin Corporation	EUR 198.5M	70.1M	2024-12
Medical Developments International	AUD 66.4M	1.06M	2025-06
Nektar Therapeutics	USD 301.35M	93.81M	2025-09
Neuren Pharmaceuticals	AUD 331.25M	78.46M	2025-06
Organigram Holdings	CAD 562.21M	2.4M	2025-09
Ovoca Bio	EUR 11.41M	3.36M	2022-06
Pacira	USD 1.3B	239.68M	2025-09
Perrigo	USD 10.08B	10.1M	2025-09
Pharma Mar	EUR 341.66M	6.59M	2025-09
Qiagen NV	USD 6.3B	257.54M	2025-12
Sartorius	EUR 9.61B	413.4M	2025-09
Sino Biopharmaceutical	CNY 74.89B	9.49B	2025-06
Supernus Pharmaceuticals	USD 1.42B	37.35M	2025-09
Tilray	USD 2.07B	1.33B	2025-03
Zz Pientze Pharmaceu	CNY 17.48B	1.23B	2025-09

Xeris Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.